

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 5.49999852 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 5.49999852 |
| 3 | epithelial cell fate commitment (GO:0072148) | 4.84950061 |
| 4 | exocrine pancreas development (GO:0031017) | 4.62466396 |
| 5 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 4.55956250 |
| 6 | positive regulation by symbiont of host defense response (GO:0052509) | 4.32933177 |
| 7 | modulation by symbiont of host defense response (GO:0052031) | 4.32933177 |
| 8 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.32933177 |
| 9 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.32933177 |
| 10 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.32933177 |
| 11 | modulation by symbiont of host immune response (GO:0052553) | 4.32933177 |
| 12 | protein localization to endosome (GO:0036010) | 4.20677282 |
| 13 | response to peptidoglycan (GO:0032494) | 4.14125476 |
| 14 | type B pancreatic cell development (GO:0003323) | 4.13753975 |
| 15 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 4.03952487 |
| 16 | lung epithelium development (GO:0060428) | 4.02522079 |
| 17 | chondrocyte proliferation (GO:0035988) | 3.96951301 |
| 18 | negative regulation of interleukin-12 production (GO:0032695) | 3.89718945 |
| 19 | cellular response to type I interferon (GO:0071357) | 3.86276174 |
| 20 | type I interferon signaling pathway (GO:0060337) | 3.86276174 |
| 21 | protein retention in ER lumen (GO:0006621) | 3.84550655 |
| 22 | detection of molecule of bacterial origin (GO:0032490) | 3.82742980 |
| 23 | response to type I interferon (GO:0034340) | 3.80500624 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.72671448 |
| 25 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.66779332 |
| 26 | signal peptide processing (GO:0006465) | 3.65810468 |
| 27 | positive regulation of tyrosine phosphorylation of Stat1 protein (GO:0042511) | 3.61932471 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.57528933 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.57528933 |
| 30 | positive regulation of nuclease activity (GO:0032075) | 3.56672963 |
| 31 | COPII vesicle coating (GO:0048208) | 3.53481542 |
| 32 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 3.51997196 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.51840259 |
| 34 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.50986960 |
| 35 | glandular epithelial cell differentiation (GO:0002067) | 3.50716879 |
| 36 | endocardial cushion morphogenesis (GO:0003203) | 3.45747086 |
| 37 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.45069632 |
| 38 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.41537043 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.39300628 |
| 40 | detection of other organism (GO:0098543) | 3.36540745 |
| 41 | positive regulation of keratinocyte differentiation (GO:0045618) | 3.32701419 |
| 42 | Notch signaling involved in heart development (GO:0061314) | 3.30885408 |
| 43 | regulation of endothelial cell chemotaxis (GO:2001026) | 3.30809903 |
| 44 | regulation of nuclease activity (GO:0032069) | 3.30637134 |
| 45 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.29449963 |
| 46 | L-phenylalanine catabolic process (GO:0006559) | 3.29449963 |
| 47 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.26018451 |
| 48 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.22470588 |
| 49 | detection of external biotic stimulus (GO:0098581) | 3.22374234 |
| 50 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 3.21340304 |
| 51 | valine metabolic process (GO:0006573) | 3.21106519 |
| 52 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.20030909 |
| 53 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.19071186 |
| 54 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.18378880 |
| 55 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 3.15042704 |
| 56 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.14894033 |
| 57 | glandular epithelial cell development (GO:0002068) | 3.13627994 |
| 58 | cellular response to interferon-alpha (GO:0035457) | 3.13420750 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 3.11242472 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.11242472 |
| 61 | cellular response to unfolded protein (GO:0034620) | 3.11137820 |
| 62 | IMP biosynthetic process (GO:0006188) | 3.05541554 |
| 63 | detection of bacterium (GO:0016045) | 3.02268278 |
| 64 | response to interferon-alpha (GO:0035455) | 3.00389612 |
| 65 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.97563686 |
| 66 | neutrophil activation involved in immune response (GO:0002283) | 2.96469524 |
| 67 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.95793532 |
| 68 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.95072933 |
| 69 | NIK/NF-kappaB signaling (GO:0038061) | 2.94756011 |
| 70 | folic acid metabolic process (GO:0046655) | 2.94409035 |
| 71 | ER-nucleus signaling pathway (GO:0006984) | 2.93915674 |
| 72 | cellular response to topologically incorrect protein (GO:0035967) | 2.92828379 |
| 73 | venous blood vessel morphogenesis (GO:0048845) | 2.92374445 |
| 74 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.91957116 |
| 75 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.91698951 |
| 76 | response to host immune response (GO:0052572) | 2.91220841 |
| 77 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.91220841 |
| 78 | leukocyte aggregation (GO:0070486) | 2.91151902 |
| 79 | myoblast migration (GO:0051451) | 2.90579658 |
| 80 | positive regulation of type 2 immune response (GO:0002830) | 2.90226307 |
| 81 | cell adhesion mediated by integrin (GO:0033627) | 2.90018237 |
| 82 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.89366616 |
| 83 | atrioventricular valve morphogenesis (GO:0003181) | 2.89174766 |
| 84 | regulation of interferon-alpha production (GO:0032647) | 2.88863649 |
| 85 | regulation of extracellular matrix organization (GO:1903053) | 2.88420401 |
| 86 | response to host (GO:0075136) | 2.88174859 |
| 87 | response to host defenses (GO:0052200) | 2.88174859 |
| 88 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.88174859 |
| 89 | midgut development (GO:0007494) | 2.87693067 |
| 90 | response to laminar fluid shear stress (GO:0034616) | 2.87473372 |
| 91 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.86258860 |
| 92 | positive regulation of interferon-alpha production (GO:0032727) | 2.81731438 |
| 93 | regulation of vitamin metabolic process (GO:0030656) | 2.81057794 |
| 94 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.80321833 |
| 95 | regulation of necroptotic process (GO:0060544) | 2.76958501 |
| 96 | glycine metabolic process (GO:0006544) | 2.76729030 |
| 97 | detection of biotic stimulus (GO:0009595) | 2.73739200 |
| 98 | coronary vasculature morphogenesis (GO:0060977) | 2.73676581 |
| 99 | tryptophan metabolic process (GO:0006568) | 2.72489078 |
| 100 | aromatic amino acid family catabolic process (GO:0009074) | 2.72428184 |
| 101 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.72351101 |
| 102 | immunoglobulin mediated immune response (GO:0016064) | 2.71985832 |
| 103 | purine nucleobase biosynthetic process (GO:0009113) | 2.71704727 |
| 104 | regulation of type 2 immune response (GO:0002828) | 2.70995553 |
| 105 | lens fiber cell development (GO:0070307) | 2.70517860 |
| 106 | vitamin transmembrane transport (GO:0035461) | 2.68262035 |
| 107 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.68162474 |
| 108 | germinal center formation (GO:0002467) | 2.65141766 |
| 109 | skin morphogenesis (GO:0043589) | 2.62729852 |
| 110 | myeloid dendritic cell differentiation (GO:0043011) | 2.62361783 |
| 111 | protein maturation by protein folding (GO:0022417) | 2.62357761 |
| 112 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.62034899 |
| 113 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.61628993 |
| 114 | cellular extravasation (GO:0045123) | 2.61119810 |
| 115 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58370821 |
| 116 | stress fiber assembly (GO:0043149) | 2.57490404 |
| 117 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.57070417 |
| 118 | regulation of leukocyte degranulation (GO:0043300) | 2.56419158 |
| 119 | protein carboxylation (GO:0018214) | 2.54018689 |
| 120 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.54018689 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.53625681 |
| 122 | cell migration involved in heart development (GO:0060973) | 2.52813749 |
| 123 | tryptophan catabolic process (GO:0006569) | 2.52725879 |
| 124 | indole-containing compound catabolic process (GO:0042436) | 2.52725879 |
| 125 | indolalkylamine catabolic process (GO:0046218) | 2.52725879 |
| 126 | alpha-linolenic acid metabolic process (GO:0036109) | 2.52486670 |
| 127 | nucleobase biosynthetic process (GO:0046112) | 2.51749528 |
| 128 | peptide catabolic process (GO:0043171) | 2.51685007 |
| 129 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.51603282 |
| 130 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.48351405 |
| 131 | mannose metabolic process (GO:0006013) | 2.48311155 |
| 132 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.46253600 |
| 133 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.45892071 |
| 134 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.45892071 |
| 135 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.45577300 |
| 136 | amyloid precursor protein catabolic process (GO:0042987) | 2.45254781 |
| 137 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.44642878 |
| 138 | cellular zinc ion homeostasis (GO:0006882) | 2.44565187 |
| 139 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.44419652 |
| 140 | inner ear receptor cell differentiation (GO:0060113) | 2.43361411 |
| 141 | macrophage activation (GO:0042116) | 2.42636614 |
| 142 | granulocyte activation (GO:0036230) | 2.41702253 |
| 143 | cellular response to virus (GO:0098586) | 2.41562651 |
| 144 | serine family amino acid catabolic process (GO:0009071) | 2.41089434 |
| 145 | mesenchyme morphogenesis (GO:0072132) | 2.40927093 |
| 146 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.40859707 |
| 147 | nucleotide-sugar metabolic process (GO:0009225) | 2.40846586 |
| 148 | sequestering of metal ion (GO:0051238) | 2.40240692 |
| 149 | IMP metabolic process (GO:0046040) | 2.40039151 |
| 150 | endocrine pancreas development (GO:0031018) | 2.39852795 |
| 151 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.39277492 |
| 152 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.39054781 |
| 153 | response to endoplasmic reticulum stress (GO:0034976) | 2.38611789 |
| 154 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.38508727 |
| 155 | regulation of RIG-I signaling pathway (GO:0039535) | 2.38117107 |
| 156 | positive regulation of interferon-beta production (GO:0032728) | 2.37637698 |
| 157 | negative regulation of type 2 immune response (GO:0002829) | 2.37334402 |
| 158 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.36667067 |
| 159 | interferon-gamma secretion (GO:0072643) | 2.35836877 |
| 160 | negative regulation of T cell mediated immunity (GO:0002710) | 2.35791426 |
| 161 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 2.35386946 |
| 162 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 2.35334392 |
| 163 | pinocytosis (GO:0006907) | 2.35184070 |
| 164 | high-density lipoprotein particle remodeling (GO:0034375) | 2.34954102 |
| 165 | respiratory burst (GO:0045730) | 2.34855653 |
| 166 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34522067 |
| 167 | glycosphingolipid catabolic process (GO:0046479) | 2.33839581 |
| 168 | regulation of necrotic cell death (GO:0010939) | 2.33633101 |
| 169 | modulation by symbiont of host cellular process (GO:0044068) | 2.33523599 |
| 170 | regulation of toll-like receptor signaling pathway (GO:0034121) | 2.33184056 |
| 171 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.33154116 |
| 172 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.30856301 |
| 173 | regulation of mast cell degranulation (GO:0043304) | 2.30829140 |
| 174 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.30652568 |
| 175 | columnar/cuboidal epithelial cell development (GO:0002066) | 2.30069588 |
| 176 | regulation of podosome assembly (GO:0071801) | 2.29819395 |
| 177 | protein autoprocessing (GO:0016540) | 2.29676127 |
| 178 | protein N-linked glycosylation via asparagine (GO:0018279) | 2.29613282 |
| 179 | regulation of glucokinase activity (GO:0033131) | 2.28516329 |
| 180 | regulation of hexokinase activity (GO:1903299) | 2.28516329 |
| 181 | response to muramyl dipeptide (GO:0032495) | 2.28293939 |
| 182 | peptidyl-asparagine modification (GO:0018196) | 2.27970273 |
| 183 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.27787410 |
| 184 | sulfur amino acid catabolic process (GO:0000098) | 2.27745277 |
| 185 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.27329391 |
| 186 | cysteine metabolic process (GO:0006534) | 2.27149190 |
| 187 | serine family amino acid metabolic process (GO:0009069) | 2.27101067 |
| 188 | neutrophil activation (GO:0042119) | 2.27005664 |
| 189 | renal system development (GO:0072001) | 2.26887511 |
| 190 | somite development (GO:0061053) | 2.26655620 |
| 191 | * response to unfolded protein (GO:0006986) | 2.26559296 |
| 192 | ribosome assembly (GO:0042255) | 2.25252596 |
| 193 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.25078020 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.01326224 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.96038496 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.21190007 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.12133617 |
| 5 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.90427697 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.86458472 |
| 7 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.75653684 |
| 8 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.63493942 |
| 9 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.40731034 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37597268 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.28607075 |
| 12 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.26213964 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.25924168 |
| 14 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.23154977 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.18799057 |
| 16 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.11957869 |
| 17 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.07213439 |
| 18 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.01896891 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.00504638 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.99837784 |
| 21 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.98212264 |
| 22 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.96810996 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.94333974 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.93497359 |
| 25 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.93182720 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.92622580 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91988625 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.89329666 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 1.88021956 |
| 30 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.85864370 |
| 31 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.85654408 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.84324267 |
| 33 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.83309562 |
| 34 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.81324171 |
| 35 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.79587596 |
| 36 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78401551 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77004228 |
| 38 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.76175961 |
| 39 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.73216264 |
| 40 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72520197 |
| 41 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.70967554 |
| 42 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.68608641 |
| 43 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.68073245 |
| 44 | MAF_26560356_Chip-Seq_TH1_Human | 1.66100729 |
| 45 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.65434490 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.65356160 |
| 47 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.64977176 |
| 48 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.63060763 |
| 49 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.63019871 |
| 50 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.62601313 |
| 51 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.61540597 |
| 52 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.61022516 |
| 53 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.57004932 |
| 54 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.56130827 |
| 55 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.55968215 |
| 56 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55707935 |
| 57 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.55449410 |
| 58 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.54758201 |
| 59 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.54315410 |
| 60 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53533157 |
| 61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.52649223 |
| 62 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.51281438 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.50432358 |
| 64 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50295803 |
| 65 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.49076303 |
| 66 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.48890386 |
| 67 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47499957 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.47461012 |
| 69 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.45372000 |
| 70 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.42601192 |
| 71 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41492914 |
| 72 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.41353023 |
| 73 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.41040780 |
| 74 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.37729676 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.36547508 |
| 76 | UTX_26944678_Chip-Seq_JUKART_Human | 1.36543676 |
| 77 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.36397544 |
| 78 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35976491 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.35885194 |
| 80 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34617051 |
| 81 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.34301906 |
| 82 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.34255649 |
| 83 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.34133668 |
| 84 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.32530182 |
| 85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31054530 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.30599227 |
| 87 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.30567878 |
| 88 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.29423171 |
| 89 | MAF_26560356_Chip-Seq_TH2_Human | 1.29071616 |
| 90 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27406032 |
| 91 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.27149252 |
| 92 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26790025 |
| 93 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25640611 |
| 94 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25640611 |
| 95 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.25352141 |
| 96 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24201032 |
| 97 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.23945761 |
| 98 | KDM2B_26808549_Chip-Seq_K562_Human | 1.22630731 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 1.22593091 |
| 100 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22451597 |
| 101 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21461586 |
| 102 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.21371161 |
| 103 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21032379 |
| 104 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.20310313 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.19952052 |
| 106 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.19417781 |
| 107 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.18751948 |
| 108 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.18322837 |
| 109 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.18079977 |
| 110 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.18032753 |
| 111 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17141424 |
| 112 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.16532261 |
| 113 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.15440540 |
| 114 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14364593 |
| 115 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14073136 |
| 116 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.13781976 |
| 117 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13699284 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13589388 |
| 119 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.13531133 |
| 120 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12896957 |
| 121 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12677180 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.12346145 |
| 123 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.12262996 |
| 124 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.11659696 |
| 125 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.11642186 |
| 126 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11613243 |
| 127 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.11524512 |
| 128 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.11385102 |
| 129 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.10913102 |
| 130 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.10871639 |
| 131 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.09715018 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.09536565 |
| 133 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.08664696 |
| 134 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.07029258 |
| 135 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.06508443 |
| 136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.06091091 |
| 137 | MYB_26560356_Chip-Seq_TH2_Human | 1.05608448 |
| 138 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.05403315 |
| 139 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.04881507 |
| 140 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.04594470 |
| 141 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.03981108 |
| 142 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03834699 |
| 143 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.03649941 |
| 144 | MYB_26560356_Chip-Seq_TH1_Human | 1.02702295 |
| 145 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.02656507 |
| 146 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.02643851 |
| 147 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.02494988 |
| 148 | * POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.00634796 |
| 149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99999252 |
| 150 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99867148 |
| 151 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99417498 |
| 152 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98320880 |
| 153 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97265187 |
| 154 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95990383 |
| 155 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95636711 |
| 156 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.94964484 |
| 157 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.94118763 |
| 158 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93978489 |
| 159 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.93802673 |
| 160 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92663772 |
| 161 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.92400577 |
| 162 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92198587 |
| 163 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.91339230 |
| 164 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.91283045 |
| 165 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.91144116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000566_synostosis | 4.49208829 |
| 2 | MP0003303_peritoneal_inflammation | 3.95764682 |
| 3 | MP0009780_abnormal_chondrocyte_physiolo | 3.90508524 |
| 4 | MP0003724_increased_susceptibility_to | 3.53912194 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.05415851 |
| 6 | MP0002877_abnormal_melanocyte_morpholog | 3.02101231 |
| 7 | MP0003183_abnormal_peptide_metabolism | 2.93208039 |
| 8 | MP0005451_abnormal_body_composition | 2.89931732 |
| 9 | MP0008260_abnormal_autophagy | 2.74432693 |
| 10 | MP0005365_abnormal_bile_salt | 2.68968178 |
| 11 | MP0005220_abnormal_exocrine_pancreas | 2.54074676 |
| 12 | MP0006082_CNS_inflammation | 2.41629449 |
| 13 | MP0005085_abnormal_gallbladder_physiolo | 2.40260000 |
| 14 | MP0009785_altered_susceptibility_to | 2.34874270 |
| 15 | MP0005257_abnormal_intraocular_pressure | 2.26357843 |
| 16 | MP0010030_abnormal_orbit_morphology | 2.06689956 |
| 17 | MP0005025_abnormal_response_to | 2.02139006 |
| 18 | MP0003252_abnormal_bile_duct | 1.98737147 |
| 19 | MP0005360_urolithiasis | 1.93747266 |
| 20 | MP0009840_abnormal_foam_cell | 1.92877141 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.91541421 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 1.87146746 |
| 23 | MP0003693_abnormal_embryo_hatching | 1.84535081 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 1.78922851 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.76778821 |
| 26 | MP0005387_immune_system_phenotype | 1.73926914 |
| 27 | MP0001790_abnormal_immune_system | 1.73926914 |
| 28 | MP0003091_abnormal_cell_migration | 1.73709007 |
| 29 | MP0001958_emphysema | 1.64503358 |
| 30 | MP0003453_abnormal_keratinocyte_physiol | 1.62955456 |
| 31 | MP0002138_abnormal_hepatobiliary_system | 1.61040033 |
| 32 | MP0002723_abnormal_immune_serum | 1.59433641 |
| 33 | MP0002452_abnormal_antigen_presenting | 1.59418027 |
| 34 | MP0004510_myositis | 1.56501688 |
| 35 | MP0008875_abnormal_xenobiotic_pharmacok | 1.56417038 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.54604516 |
| 37 | MP0001800_abnormal_humoral_immune | 1.51803500 |
| 38 | MP0001944_abnormal_pancreas_morphology | 1.49439197 |
| 39 | MP0003075_altered_response_to | 1.48254168 |
| 40 | MP0003448_altered_tumor_morphology | 1.47075785 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.43459835 |
| 42 | MP0006054_spinal_hemorrhage | 1.41499869 |
| 43 | MP0009278_abnormal_bone_marrow | 1.40399332 |
| 44 | MP0009764_decreased_sensitivity_to | 1.40360567 |
| 45 | MP0001819_abnormal_immune_cell | 1.40112012 |
| 46 | MP0003123_paternal_imprinting | 1.39429170 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.39330369 |
| 48 | MP0003806_abnormal_nucleotide_metabolis | 1.38854356 |
| 49 | MP0002166_altered_tumor_susceptibility | 1.37236319 |
| 50 | MP0001666_abnormal_nutrient_absorption | 1.35302132 |
| 51 | MP0005670_abnormal_white_adipose | 1.35211520 |
| 52 | MP0002254_reproductive_system_inflammat | 1.34473752 |
| 53 | MP0003705_abnormal_hypodermis_morpholog | 1.34390746 |
| 54 | MP0000604_amyloidosis | 1.33816322 |
| 55 | MP0003868_abnormal_feces_composition | 1.32642805 |
| 56 | MP0004808_abnormal_hematopoietic_stem | 1.31238082 |
| 57 | MP0000343_altered_response_to | 1.29452811 |
| 58 | MP0002089_abnormal_postnatal_growth/wei | 1.28935307 |
| 59 | MP0003195_calcinosis | 1.27541418 |
| 60 | MP0005164_abnormal_response_to | 1.27023341 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.26375518 |
| 62 | MP0010329_abnormal_lipoprotein_level | 1.26045787 |
| 63 | MP0002693_abnormal_pancreas_physiology | 1.25820839 |
| 64 | MP0002405_respiratory_system_inflammati | 1.24726995 |
| 65 | MP0010234_abnormal_vibrissa_follicle | 1.24020557 |
| 66 | MP0009697_abnormal_copulation | 1.23748485 |
| 67 | MP0000609_abnormal_liver_physiology | 1.21949482 |
| 68 | MP0002332_abnormal_exercise_endurance | 1.20987211 |
| 69 | MP0005083_abnormal_biliary_tract | 1.20559701 |
| 70 | MP0002396_abnormal_hematopoietic_system | 1.20127799 |
| 71 | MP0003941_abnormal_skin_development | 1.17689905 |
| 72 | MP0008004_abnormal_stomach_pH | 1.17654156 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.17451935 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.17451935 |
| 75 | MP0002928_abnormal_bile_duct | 1.17053694 |
| 76 | MP0003656_abnormal_erythrocyte_physiolo | 1.16913938 |
| 77 | MP0004858_abnormal_nervous_system | 1.16181985 |
| 78 | MP0005076_abnormal_cell_differentiation | 1.13196871 |
| 79 | MP0003221_abnormal_cardiomyocyte_apopto | 1.11515362 |
| 80 | MP0009643_abnormal_urine_homeostasis | 1.09707878 |
| 81 | MP0005310_abnormal_salivary_gland | 1.08043322 |
| 82 | MP0003111_abnormal_nucleus_morphology | 1.07208331 |
| 83 | MP0002009_preneoplasia | 1.06989745 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.06610641 |
| 85 | MP0005166_decreased_susceptibility_to | 1.05016059 |
| 86 | MP0003943_abnormal_hepatobiliary_system | 1.04797011 |
| 87 | MP0003436_decreased_susceptibility_to | 1.04579679 |
| 88 | MP0000716_abnormal_immune_system | 1.04182314 |
| 89 | MP0003077_abnormal_cell_cycle | 1.03383657 |
| 90 | MP0003329_amyloid_beta_deposits | 1.03341154 |
| 91 | MP0000428_abnormal_craniofacial_morphol | 1.02202460 |
| 92 | MP0005058_abnormal_lysosome_morphology | 1.01925075 |
| 93 | MP0000767_abnormal_smooth_muscle | 1.01366255 |
| 94 | MP0001542_abnormal_bone_strength | 1.00703208 |
| 95 | MP0004233_abnormal_muscle_weight | 1.00242756 |
| 96 | MP0001849_ear_inflammation | 0.99871806 |
| 97 | MP0005409_darkened_coat_color | 0.99733049 |
| 98 | MP0000858_altered_metastatic_potential | 0.99104717 |
| 99 | MP0005332_abnormal_amino_acid | 0.97827564 |
| 100 | MP0001873_stomach_inflammation | 0.97343368 |
| 101 | MP0001835_abnormal_antigen_presentation | 0.95035208 |
| 102 | MP0010368_abnormal_lymphatic_system | 0.94927989 |
| 103 | MP0000598_abnormal_liver_morphology | 0.94868359 |
| 104 | MP0002398_abnormal_bone_marrow | 0.92181329 |
| 105 | MP0005623_abnormal_meninges_morphology | 0.92017773 |
| 106 | MP0005390_skeleton_phenotype | 0.91705730 |
| 107 | MP0000371_diluted_coat_color | 0.90268330 |
| 108 | MP0004883_abnormal_blood_vessel | 0.90233036 |
| 109 | MP0004381_abnormal_hair_follicle | 0.89178407 |
| 110 | MP0001533_abnormal_skeleton_physiology | 0.89166575 |
| 111 | MP0001915_intracranial_hemorrhage | 0.88838722 |
| 112 | MP0005275_abnormal_skin_tensile | 0.88290550 |
| 113 | MP0010307_abnormal_tumor_latency | 0.87931496 |
| 114 | MP0005023_abnormal_wound_healing | 0.87562328 |
| 115 | MP0005319_abnormal_enzyme/_coenzyme | 0.87356362 |
| 116 | MP0002429_abnormal_blood_cell | 0.86316629 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.84908456 |
| 118 | MP0002118_abnormal_lipid_homeostasis | 0.84777640 |
| 119 | MP0004185_abnormal_adipocyte_glucose | 0.84051888 |
| 120 | MP0001756_abnormal_urination | 0.84036200 |
| 121 | MP0002796_impaired_skin_barrier | 0.82678008 |
| 122 | MP0000685_abnormal_immune_system | 0.82513998 |
| 123 | MP0004272_abnormal_basement_membrane | 0.82104497 |
| 124 | MP0002722_abnormal_immune_system | 0.82096482 |
| 125 | MP0003828_pulmonary_edema | 0.81940612 |
| 126 | MP0009763_increased_sensitivity_to | 0.79728857 |
| 127 | MP0003866_abnormal_defecation | 0.79552958 |
| 128 | MP0002006_tumorigenesis | 0.79196279 |
| 129 | MP0003566_abnormal_cell_adhesion | 0.79091898 |
| 130 | MP0000490_abnormal_crypts_of | 0.79079891 |
| 131 | MP0008874_decreased_physiological_sensi | 0.79027128 |
| 132 | MP0009333_abnormal_splenocyte_physiolog | 0.78705371 |
| 133 | MP0001216_abnormal_epidermal_layer | 0.77950565 |
| 134 | MP0003279_aneurysm | 0.77844715 |
| 135 | MP0002419_abnormal_innate_immunity | 0.77801983 |
| 136 | MP0000003_abnormal_adipose_tissue | 0.77245593 |
| 137 | MP0005621_abnormal_cell_physiology | 0.75792875 |
| 138 | MP0002060_abnormal_skin_morphology | 0.75111033 |
| 139 | MP0010352_gastrointestinal_tract_polyps | 0.74996705 |
| 140 | MP0005408_hypopigmentation | 0.74566573 |
| 141 | MP0000465_gastrointestinal_hemorrhage | 0.73598648 |
| 142 | MP0005671_abnormal_response_to | 0.71378081 |
| 143 | MP0000350_abnormal_cell_proliferation | 0.69186527 |
| 144 | MP0008469_abnormal_protein_level | 0.69164553 |
| 145 | MP0001845_abnormal_inflammatory_respons | 0.68839129 |
| 146 | MP0002088_abnormal_embryonic_growth/wei | 0.68649819 |
| 147 | MP0000537_abnormal_urethra_morphology | 0.68600452 |
| 148 | MP0003984_embryonic_growth_retardation | 0.68282163 |
| 149 | MP0002078_abnormal_glucose_homeostasis | 0.68076031 |
| 150 | MP0005084_abnormal_gallbladder_morpholo | 0.67556676 |
| 151 | MP0001299_abnormal_eye_distance/ | 0.67287547 |
| 152 | MP0003172_abnormal_lysosome_physiology | 0.67231431 |
| 153 | MP0005508_abnormal_skeleton_morphology | 0.66949830 |
| 154 | MP0001661_extended_life_span | 0.66747730 |
| 155 | MP0010155_abnormal_intestine_physiology | 0.65843132 |
| 156 | MP0003763_abnormal_thymus_physiology | 0.65337273 |
| 157 | MP0002086_abnormal_extraembryonic_tissu | 0.63784984 |
| 158 | MP0004947_skin_inflammation | 0.63554866 |
| 159 | MP0003186_abnormal_redox_activity | 0.62818675 |
| 160 | MP0001853_heart_inflammation | 0.62529689 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 4.07928309 |
| 2 | Abnormality of macrophages (HP:0004311) | 3.81022927 |
| 3 | Abnormality of the intrinsic pathway (HP:0010989) | 3.78690348 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.75326400 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.75326400 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 3.75326400 |
| 7 | Abnormality of the lumbar spine (HP:0100712) | 3.60085515 |
| 8 | Neonatal short-limb short stature (HP:0008921) | 3.57201364 |
| 9 | Orchitis (HP:0100796) | 3.52592384 |
| 10 | Progressive muscle weakness (HP:0003323) | 3.40717340 |
| 11 | Myositis (HP:0100614) | 3.25323854 |
| 12 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.24203305 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.23273635 |
| 14 | Recurrent bacterial skin infections (HP:0005406) | 3.19528309 |
| 15 | Hypoglycemic coma (HP:0001325) | 3.17195345 |
| 16 | Retrobulbar optic neuritis (HP:0100654) | 3.10919039 |
| 17 | Optic neuritis (HP:0100653) | 3.10919039 |
| 18 | Peritonitis (HP:0002586) | 3.09964782 |
| 19 | Protrusio acetabuli (HP:0003179) | 3.08227097 |
| 20 | Vertebral compression fractures (HP:0002953) | 2.96393326 |
| 21 | Abnormality of the common coagulation pathway (HP:0010990) | 2.90855539 |
| 22 | Intrahepatic cholestasis (HP:0001406) | 2.87534790 |
| 23 | Neonatal death (HP:0003811) | 2.82498327 |
| 24 | Partial duplication of thumb phalanx (HP:0009944) | 2.77835029 |
| 25 | Hyperglycemia (HP:0003074) | 2.73937101 |
| 26 | Aortic aneurysm (HP:0004942) | 2.73649866 |
| 27 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.69832236 |
| 28 | Loss of speech (HP:0002371) | 2.67986100 |
| 29 | Thrombocytosis (HP:0001894) | 2.66786977 |
| 30 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.66548298 |
| 31 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.63592894 |
| 32 | Xanthomatosis (HP:0000991) | 2.60223688 |
| 33 | Hypoglycemic seizures (HP:0002173) | 2.53681469 |
| 34 | Degeneration of anterior horn cells (HP:0002398) | 2.49672025 |
| 35 | Abnormality of the anterior horn cell (HP:0006802) | 2.49672025 |
| 36 | Gastrointestinal infarctions (HP:0005244) | 2.48807344 |
| 37 | Spondylolisthesis (HP:0003302) | 2.48340769 |
| 38 | Hepatocellular carcinoma (HP:0001402) | 2.46660114 |
| 39 | Ureteral duplication (HP:0000073) | 2.44196629 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.42577038 |
| 41 | Thin bony cortex (HP:0002753) | 2.42258798 |
| 42 | Prolonged partial thromboplastin time (HP:0003645) | 2.41764065 |
| 43 | Abnormality of the costochondral junction (HP:0000919) | 2.40485473 |
| 44 | Partial duplication of the phalanx of hand (HP:0009999) | 2.39535019 |
| 45 | Subacute progressive viral hepatitis (HP:0006572) | 2.37856761 |
| 46 | Dysostosis multiplex (HP:0000943) | 2.35457160 |
| 47 | Hyperglycinemia (HP:0002154) | 2.34894044 |
| 48 | Abnormality of complement system (HP:0005339) | 2.34765911 |
| 49 | Amyloidosis (HP:0011034) | 2.34013220 |
| 50 | Infantile muscular hypotonia (HP:0008947) | 2.33957591 |
| 51 | Vacuolated lymphocytes (HP:0001922) | 2.30798894 |
| 52 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.30083484 |
| 53 | Gingivitis (HP:0000230) | 2.29514603 |
| 54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.29208797 |
| 55 | Mucopolysacchariduria (HP:0008155) | 2.29208797 |
| 56 | Conjugated hyperbilirubinemia (HP:0002908) | 2.26029565 |
| 57 | Dilatation of the ascending aorta (HP:0005111) | 2.25926165 |
| 58 | Flat acetabular roof (HP:0003180) | 2.24774565 |
| 59 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.24616567 |
| 60 | Aplasia of the phalanges of the hand (HP:0009802) | 2.24616567 |
| 61 | Aplasia involving bones of the extremities (HP:0009825) | 2.24616567 |
| 62 | Generalized aminoaciduria (HP:0002909) | 2.24462142 |
| 63 | Micronodular cirrhosis (HP:0001413) | 2.24306435 |
| 64 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.24292429 |
| 65 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.24292429 |
| 66 | Deep venous thrombosis (HP:0002625) | 2.22466518 |
| 67 | Cellulitis (HP:0100658) | 2.21319153 |
| 68 | Esophageal varix (HP:0002040) | 2.19744661 |
| 69 | Joint hemorrhage (HP:0005261) | 2.19669635 |
| 70 | Mediastinal lymphadenopathy (HP:0100721) | 2.18196166 |
| 71 | Menorrhagia (HP:0000132) | 2.17272749 |
| 72 | Nonimmune hydrops fetalis (HP:0001790) | 2.16702778 |
| 73 | Testicular atrophy (HP:0000029) | 2.13996132 |
| 74 | Systemic lupus erythematosus (HP:0002725) | 2.13615276 |
| 75 | Premature rupture of membranes (HP:0001788) | 2.12216365 |
| 76 | Gout (HP:0001997) | 2.11730643 |
| 77 | Cervical subluxation (HP:0003308) | 2.11634929 |
| 78 | Myocardial infarction (HP:0001658) | 2.09493674 |
| 79 | Long toe (HP:0010511) | 2.09052568 |
| 80 | Short nail (HP:0001799) | 2.08833729 |
| 81 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.08493257 |
| 82 | Generalized amyotrophy (HP:0003700) | 2.08354824 |
| 83 | Increased connective tissue (HP:0009025) | 2.07067349 |
| 84 | Achilles tendon contracture (HP:0001771) | 2.06137178 |
| 85 | Increased cerebral lipofuscin (HP:0011813) | 2.05501614 |
| 86 | Mitral stenosis (HP:0001718) | 2.04845911 |
| 87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04615317 |
| 88 | Osteolytic defects of the hand bones (HP:0009699) | 2.04615317 |
| 89 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.04330075 |
| 90 | Insulin resistance (HP:0000855) | 2.03644029 |
| 91 | Symptomatic seizures (HP:0011145) | 2.03295113 |
| 92 | Hypoplastic scapulae (HP:0000882) | 2.03197314 |
| 93 | Aplasia/Hypoplasia of the scapulae (HP:0006713) | 2.03197314 |
| 94 | Keratoconjunctivitis sicca (HP:0001097) | 2.03058109 |
| 95 | Late onset (HP:0003584) | 2.02973428 |
| 96 | Atrophic scars (HP:0001075) | 2.00727729 |
| 97 | Cerebral aneurysm (HP:0004944) | 2.00660635 |
| 98 | Recurrent corneal erosions (HP:0000495) | 1.99167738 |
| 99 | Vascular tortuosity (HP:0004948) | 1.99146090 |
| 100 | Gonadal dysgenesis (HP:0000133) | 1.99125851 |
| 101 | Hemorrhage of the eye (HP:0011885) | 1.98852192 |
| 102 | Increased serum ferritin (HP:0003281) | 1.97566307 |
| 103 | Entropion (HP:0000621) | 1.97055212 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 1.97022620 |
| 105 | Cerebral inclusion bodies (HP:0100314) | 1.96910757 |
| 106 | Hypobetalipoproteinemia (HP:0003563) | 1.96601036 |
| 107 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.96053265 |
| 108 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.96053265 |
| 109 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.96053265 |
| 110 | Complement deficiency (HP:0004431) | 1.96006186 |
| 111 | Recurrent skin infections (HP:0001581) | 1.95681566 |
| 112 | Malnutrition (HP:0004395) | 1.95432159 |
| 113 | Genu recurvatum (HP:0002816) | 1.95026454 |
| 114 | Arterial tortuosity (HP:0005116) | 1.94548433 |
| 115 | Stomatitis (HP:0010280) | 1.93860590 |
| 116 | Spontaneous hematomas (HP:0007420) | 1.93615055 |
| 117 | Ankle contracture (HP:0006466) | 1.92712658 |
| 118 | Recurrent fungal infections (HP:0002841) | 1.92245526 |
| 119 | Hyperglycinuria (HP:0003108) | 1.90554793 |
| 120 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.90507655 |
| 121 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.90070769 |
| 122 | Arterial thrombosis (HP:0004420) | 1.89902945 |
| 123 | Abnormality of the peritoneum (HP:0002585) | 1.89814910 |
| 124 | Abnormality of the Achilles tendon (HP:0005109) | 1.89663443 |
| 125 | Hyperlipoproteinemia (HP:0010980) | 1.89221781 |
| 126 | Ketosis (HP:0001946) | 1.87714536 |
| 127 | Abnormality of nucleobase metabolism (HP:0010932) | 1.87345080 |
| 128 | Urticaria (HP:0001025) | 1.87172026 |
| 129 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.87006892 |
| 130 | Upper motor neuron abnormality (HP:0002127) | 1.86882296 |
| 131 | Aortic dissection (HP:0002647) | 1.86513450 |
| 132 | Neurofibrillary tangles (HP:0002185) | 1.86314392 |
| 133 | Fat malabsorption (HP:0002630) | 1.86186881 |
| 134 | Blue sclerae (HP:0000592) | 1.85474747 |
| 135 | Visceral angiomatosis (HP:0100761) | 1.85426831 |
| 136 | Slow saccadic eye movements (HP:0000514) | 1.84486233 |
| 137 | Hematochezia (HP:0002573) | 1.84456879 |
| 138 | Gingival bleeding (HP:0000225) | 1.82228491 |
| 139 | Camptodactyly of toe (HP:0001836) | 1.82184174 |
| 140 | Obstructive lung disease (HP:0006536) | 1.80585583 |
| 141 | Chronic obstructive pulmonary disease (HP:0006510) | 1.80585583 |
| 142 | Aortic regurgitation (HP:0001659) | 1.80492575 |
| 143 | Bone pain (HP:0002653) | 1.79614497 |
| 144 | Abnormality of purine metabolism (HP:0004352) | 1.78852582 |
| 145 | Syringomyelia (HP:0003396) | 1.78829850 |
| 146 | Spinal cord lesions (HP:0100561) | 1.78829850 |
| 147 | Glucose intolerance (HP:0000833) | 1.78699415 |
| 148 | Adactyly (HP:0009776) | 1.78376807 |
| 149 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.78084324 |
| 150 | Abnormality of glycine metabolism (HP:0010895) | 1.77902228 |
| 151 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.77902228 |
| 152 | Keratoconjunctivitis (HP:0001096) | 1.77660499 |
| 153 | Vasculitis (HP:0002633) | 1.76684803 |
| 154 | Coronal craniosynostosis (HP:0004440) | 1.75208887 |
| 155 | Pathologic fracture (HP:0002756) | 1.74905060 |
| 156 | Hemangiomatosis (HP:0007461) | 1.74462571 |
| 157 | Prominent metopic ridge (HP:0005487) | 1.74339596 |
| 158 | Impaired platelet aggregation (HP:0003540) | 1.73945348 |
| 159 | Abnormal platelet function (HP:0011869) | 1.73945348 |
| 160 | Megalencephaly (HP:0001355) | 1.73940519 |
| 161 | Ovoid vertebral bodies (HP:0003300) | 1.73150343 |
| 162 | Abnormality of the pericardium (HP:0001697) | 1.72700301 |
| 163 | Episodic fever (HP:0001954) | 1.72532768 |
| 164 | Alopecia of scalp (HP:0002293) | 1.72060959 |
| 165 | Wormian bones (HP:0002645) | 1.72052031 |
| 166 | 11 pairs of ribs (HP:0000878) | 1.71960676 |
| 167 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.71942069 |
| 168 | Increased IgE level (HP:0003212) | 1.71853212 |
| 169 | Asymmetric septal hypertrophy (HP:0001670) | 1.71257572 |
| 170 | Hyperbilirubinemia (HP:0002904) | 1.70965080 |
| 171 | Abnormality of the middle phalanges of the toes (HP:0010183) | 1.70791459 |
| 172 | Striae distensae (HP:0001065) | 1.70258596 |
| 173 | Fragile skin (HP:0001030) | 1.70129241 |
| 174 | Aneurysm (HP:0002617) | 1.69961505 |
| 175 | Aseptic necrosis (HP:0010885) | 1.67869710 |
| 176 | Recurrent viral infections (HP:0004429) | 1.67750371 |
| 177 | Anorexia (HP:0002039) | 1.66323114 |
| 178 | Tetraparesis (HP:0002273) | 1.65871564 |
| 179 | Polycythemia (HP:0001901) | 1.65728833 |
| 180 | Persistence of primary teeth (HP:0006335) | 1.64788312 |
| 181 | Distal lower limb muscle weakness (HP:0009053) | 1.62520554 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 5.45952140 |
| 2 | IRAK3 | 3.77028823 |
| 3 | TESK2 | 3.71774521 |
| 4 | ERN1 | 3.14578593 |
| 5 | PRPF4B | 2.83338510 |
| 6 | FGFR3 | 2.77170967 |
| 7 | CDK8 | 2.69837626 |
| 8 | BCKDK | 2.48515444 |
| 9 | FRK | 2.28247243 |
| 10 | EPHB1 | 2.10880895 |
| 11 | RIPK4 | 2.07012251 |
| 12 | TAOK2 | 2.06981704 |
| 13 | TAOK3 | 2.06922909 |
| 14 | NME2 | 1.98103083 |
| 15 | BLK | 1.95828901 |
| 16 | PASK | 1.94227910 |
| 17 | BRSK2 | 1.87053525 |
| 18 | MKNK2 | 1.84134362 |
| 19 | KSR2 | 1.66744546 |
| 20 | FLT3 | 1.63606749 |
| 21 | TAOK1 | 1.63146352 |
| 22 | INSRR | 1.62902572 |
| 23 | SCYL2 | 1.61608666 |
| 24 | AKT3 | 1.60674165 |
| 25 | MAP2K3 | 1.58341214 |
| 26 | RPS6KA4 | 1.57387252 |
| 27 | NEK9 | 1.55870666 |
| 28 | IRAK4 | 1.52727285 |
| 29 | MAP3K1 | 1.50166524 |
| 30 | SMG1 | 1.49307260 |
| 31 | ICK | 1.49294977 |
| 32 | TESK1 | 1.47265435 |
| 33 | TYK2 | 1.41936713 |
| 34 | MAP3K13 | 1.35606302 |
| 35 | TRIB3 | 1.32967383 |
| 36 | MAP3K3 | 1.32320008 |
| 37 | MAP3K14 | 1.31124470 |
| 38 | MOS | 1.29306595 |
| 39 | SIK3 | 1.24913430 |
| 40 | PKN2 | 1.22973692 |
| 41 | PIM2 | 1.21006279 |
| 42 | NEK2 | 1.19024872 |
| 43 | FGR | 1.18468584 |
| 44 | MAP3K6 | 1.17865948 |
| 45 | GRK6 | 1.17304295 |
| 46 | FGFR1 | 1.15994047 |
| 47 | CDK4 | 1.14788614 |
| 48 | MATK | 1.12143079 |
| 49 | MAP4K1 | 1.11604628 |
| 50 | TGFBR2 | 1.09840727 |
| 51 | DYRK3 | 1.09282554 |
| 52 | CDC42BPA | 1.07215906 |
| 53 | EPHA2 | 1.05824906 |
| 54 | PRKD2 | 1.05730649 |
| 55 | JAK3 | 1.04324875 |
| 56 | PIK3CG | 1.04028327 |
| 57 | SIK1 | 1.03334771 |
| 58 | LATS2 | 1.03054978 |
| 59 | RIPK1 | 1.02329839 |
| 60 | MKNK1 | 1.01129143 |
| 61 | HIPK2 | 0.99612507 |
| 62 | LATS1 | 0.97169096 |
| 63 | ARAF | 0.94447781 |
| 64 | CDK9 | 0.94422255 |
| 65 | DDR2 | 0.92640499 |
| 66 | MST1R | 0.92267458 |
| 67 | MAP3K2 | 0.92202426 |
| 68 | EIF2AK3 | 0.91572918 |
| 69 | NLK | 0.90310651 |
| 70 | STK10 | 0.89956413 |
| 71 | MELK | 0.89711977 |
| 72 | NUAK1 | 0.89613673 |
| 73 | KSR1 | 0.88989564 |
| 74 | MAP3K10 | 0.88958856 |
| 75 | PTK6 | 0.88526108 |
| 76 | TTN | 0.87902821 |
| 77 | BTK | 0.87098149 |
| 78 | JAK1 | 0.86065249 |
| 79 | CHUK | 0.85250924 |
| 80 | TEC | 0.83752011 |
| 81 | MARK2 | 0.83320408 |
| 82 | TLK1 | 0.83121007 |
| 83 | GRK7 | 0.83065431 |
| 84 | ZAP70 | 0.81216799 |
| 85 | BMPR2 | 0.80042061 |
| 86 | TIE1 | 0.79456720 |
| 87 | IRAK2 | 0.78031272 |
| 88 | ERBB3 | 0.77542118 |
| 89 | KIT | 0.75691842 |
| 90 | ZAK | 0.74471979 |
| 91 | HCK | 0.73723833 |
| 92 | PDPK1 | 0.73363815 |
| 93 | CDK6 | 0.72717592 |
| 94 | FGFR4 | 0.71540418 |
| 95 | PIM1 | 0.70569012 |
| 96 | IRAK1 | 0.66300879 |
| 97 | RAF1 | 0.65627547 |
| 98 | ATR | 0.65557265 |
| 99 | SRPK1 | 0.64959747 |
| 100 | MARK3 | 0.64887945 |
| 101 | PTK2 | 0.64805026 |
| 102 | LMTK2 | 0.64493494 |
| 103 | TXK | 0.64418753 |
| 104 | PRKD3 | 0.63708777 |
| 105 | DYRK1B | 0.63260372 |
| 106 | STK38 | 0.63120149 |
| 107 | AURKB | 0.62397451 |
| 108 | YES1 | 0.62093907 |
| 109 | LRRK2 | 0.60365311 |
| 110 | TBK1 | 0.60224010 |
| 111 | STK16 | 0.59466677 |
| 112 | MAPK11 | 0.58958647 |
| 113 | MAP3K7 | 0.58013896 |
| 114 | BMX | 0.55982559 |
| 115 | CLK1 | 0.55830711 |
| 116 | IKBKB | 0.55440604 |
| 117 | PDGFRB | 0.53904208 |
| 118 | WEE1 | 0.53780655 |
| 119 | JAK2 | 0.52136776 |
| 120 | EPHA3 | 0.51952845 |
| 121 | MAP3K11 | 0.51659732 |
| 122 | LYN | 0.50938117 |
| 123 | PLK1 | 0.50455603 |
| 124 | PRKG2 | 0.50179608 |
| 125 | CDK7 | 0.49795411 |
| 126 | TSSK6 | 0.49047187 |
| 127 | FES | 0.48969145 |
| 128 | IKBKE | 0.48679778 |
| 129 | LCK | 0.48271025 |
| 130 | MAP3K8 | 0.47443566 |
| 131 | TGFBR1 | 0.46423750 |
| 132 | PDGFRA | 0.45930112 |
| 133 | MTOR | 0.44644314 |
| 134 | MAPKAPK2 | 0.44479408 |
| 135 | RET | 0.43782193 |
| 136 | BRD4 | 0.43005524 |
| 137 | PDK1 | 0.42290179 |
| 138 | SIK2 | 0.41748060 |
| 139 | IGF1R | 0.41576882 |
| 140 | RPS6KA2 | 0.40952644 |
| 141 | STK3 | 0.40105458 |
| 142 | ABL2 | 0.39657678 |
| 143 | STK4 | 0.39532100 |
| 144 | TRPM7 | 0.38543328 |
| 145 | PAK4 | 0.38501209 |
| 146 | TNK2 | 0.38498016 |
| 147 | CSK | 0.38393324 |
| 148 | CDK12 | 0.37303898 |
| 149 | CSF1R | 0.37058396 |
| 150 | NEK6 | 0.35437978 |
| 151 | BRSK1 | 0.34521912 |
| 152 | SYK | 0.33825057 |
| 153 | MAP3K5 | 0.32799364 |
| 154 | MAPK15 | 0.32172549 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 4.31741921 |
| 2 | Protein export_Homo sapiens_hsa03060 | 3.29119017 |
| 3 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.92742050 |
| 4 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.84042452 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.62301792 |
| 6 | Selenocompound metabolism_Homo sapiens_hsa00450 | 2.42790979 |
| 7 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.34280892 |
| 8 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.33883171 |
| 9 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.20567848 |
| 10 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.05850623 |
| 11 | Malaria_Homo sapiens_hsa05144 | 1.96151075 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.81104907 |
| 13 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.78176976 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.76600281 |
| 15 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.73313274 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.70814858 |
| 17 | Tuberculosis_Homo sapiens_hsa05152 | 1.69173086 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.65140424 |
| 19 | Hepatitis C_Homo sapiens_hsa05160 | 1.64203422 |
| 20 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.56017400 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.55865542 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55707321 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.55700389 |
| 24 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.54632493 |
| 25 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.54243334 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.53083543 |
| 27 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.52375400 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.50278135 |
| 29 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.50134420 |
| 30 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.49831087 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.46067578 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.43028309 |
| 33 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42371862 |
| 34 | Pertussis_Homo sapiens_hsa05133 | 1.40454512 |
| 35 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.40235964 |
| 36 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.33554051 |
| 37 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.33331357 |
| 38 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32975574 |
| 39 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.32552337 |
| 40 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.30777439 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.27523992 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 1.25188510 |
| 43 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.25055505 |
| 44 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.25022348 |
| 45 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.25021033 |
| 46 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.23206703 |
| 47 | Lysosome_Homo sapiens_hsa04142 | 1.21320291 |
| 48 | Amoebiasis_Homo sapiens_hsa05146 | 1.20410757 |
| 49 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.19811908 |
| 50 | Bladder cancer_Homo sapiens_hsa05219 | 1.18113375 |
| 51 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.17576126 |
| 52 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.15752583 |
| 53 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.15626072 |
| 54 | Peroxisome_Homo sapiens_hsa04146 | 1.15138187 |
| 55 | ABC transporters_Homo sapiens_hsa02010 | 1.14297063 |
| 56 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12033712 |
| 57 | Base excision repair_Homo sapiens_hsa03410 | 1.10676394 |
| 58 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.09952934 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.09232293 |
| 60 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08198476 |
| 61 | Prion diseases_Homo sapiens_hsa05020 | 1.07544261 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.06496362 |
| 63 | DNA replication_Homo sapiens_hsa03030 | 1.06175275 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.02053055 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 1.01066307 |
| 66 | Sulfur relay system_Homo sapiens_hsa04122 | 1.00405911 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.98820472 |
| 68 | Galactose metabolism_Homo sapiens_hsa00052 | 0.98420991 |
| 69 | RNA polymerase_Homo sapiens_hsa03020 | 0.96490397 |
| 70 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.96167762 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.95085512 |
| 72 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94916424 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94508954 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.92707546 |
| 75 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.90259036 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.89414082 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.88294829 |
| 78 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.87560917 |
| 79 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.87471955 |
| 80 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.87022519 |
| 81 | Endocytosis_Homo sapiens_hsa04144 | 0.87004645 |
| 82 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.86404999 |
| 83 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.86399574 |
| 84 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85934586 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85749753 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85310105 |
| 87 | Legionellosis_Homo sapiens_hsa05134 | 0.85190569 |
| 88 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.84954392 |
| 89 | Thyroid cancer_Homo sapiens_hsa05216 | 0.83775903 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83575396 |
| 91 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.83335802 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83198987 |
| 93 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.82940880 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82315616 |
| 95 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.80977916 |
| 96 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.80382201 |
| 97 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.78987413 |
| 98 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77890946 |
| 99 | Allograft rejection_Homo sapiens_hsa05330 | 0.77608670 |
| 100 | Histidine metabolism_Homo sapiens_hsa00340 | 0.77187066 |
| 101 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77077909 |
| 102 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.75053163 |
| 103 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.74119546 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.73503706 |
| 105 | Cell cycle_Homo sapiens_hsa04110 | 0.73386823 |
| 106 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.72828630 |
| 107 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72014051 |
| 108 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.70966286 |
| 109 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.68039023 |
| 110 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.66105893 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.66096676 |
| 112 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.65641308 |
| 113 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.65532556 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.62489003 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.62226892 |
| 116 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.59795421 |
| 117 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.59693642 |
| 118 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.58888756 |
| 119 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58312991 |
| 120 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57522487 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.57501431 |
| 122 | Measles_Homo sapiens_hsa05162 | 0.54601977 |
| 123 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.54456442 |
| 124 | Glioma_Homo sapiens_hsa05214 | 0.54222820 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54141441 |
| 126 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.53995802 |
| 127 | Mismatch repair_Homo sapiens_hsa03430 | 0.53817945 |
| 128 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.52710627 |
| 129 | Apoptosis_Homo sapiens_hsa04210 | 0.52273998 |
| 130 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50751499 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50624857 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.50379503 |
| 133 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.49711005 |
| 134 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.49247110 |
| 135 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.48880957 |
| 136 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.48852934 |
| 137 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47633912 |
| 138 | Platelet activation_Homo sapiens_hsa04611 | 0.46030108 |
| 139 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.46012505 |
| 140 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.45976752 |
| 141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45006617 |
| 142 | Homologous recombination_Homo sapiens_hsa03440 | 0.44692396 |
| 143 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44676132 |
| 144 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44670754 |
| 145 | Purine metabolism_Homo sapiens_hsa00230 | 0.43607565 |
| 146 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.42352212 |
| 147 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.42215465 |
| 148 | Hepatitis B_Homo sapiens_hsa05161 | 0.42156976 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41707147 |
| 150 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.41702680 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41576458 |
| 152 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.41441342 |
| 153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.41037073 |
| 154 | Prostate cancer_Homo sapiens_hsa05215 | 0.40936699 |
| 155 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.37323580 |
| 156 | Spliceosome_Homo sapiens_hsa03040 | 0.35637056 |
| 157 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.33447144 |
| 158 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.33015525 |
| 159 | HTLV-I infection_Homo sapiens_hsa05166 | 0.32968459 |
| 160 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.32575906 |
| 161 | Influenza A_Homo sapiens_hsa05164 | 0.32384991 |
| 162 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30880358 |
| 163 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30576604 |
| 164 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.29632298 |

